SciAps Inc

WOBURN, MA · Founded 2012 · CIK 0001570867 · Medtech · Acquired

Portable X-ray fluorescence (XRF) and laser-induced breakdown spectroscopy (LIBS) instruments for elemental analysis

sciaps.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$51M
13 Form D · May 2023
41 months since last filing
Contracts
—
No federal contracts on record
Patents
40
26 granted · 14 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$1,516,962
Private capital raisedForm D · SEC$1,000,000
Private capital raisedForm D · SEC$2,584,224
Private capital raisedForm D · SEC$3,117,548
Private capital raisedForm D · SEC$4,300,003
Private capital raisedForm D · SEC$1,043,179
Private capital raisedForm D · SEC$1,593,079
Private capital raisedForm D · SEC$1,940,186
Private capital raisedForm D · SEC$7,370,940
Private capital raisedForm D · SEC$12,500,000
Private capital raisedForm D · SEC$3,000,000
Private capital raisedForm D · SEC$7,219,992
Private capital raisedForm D · SEC$3,965,330
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1656ARKAYLI BIOPHARMA, INC.——
1657Ting-Pau Oei——
1658MAGURO SURGICAL INC——
1659SciAps Inc—$51M
1660Imagine Devices Inc.—$300K
1661MFB FERTILITY INC——
1662Fisher Wallace Laboratories, Inc.—$250K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 11 related persons
  • Jeffrey BurkeDirector
  • William ClarkeDirector
  • Christopher DavisDirector
  • David DayDirector
  • Charles GilliesDirector
  • Gary LortieDirector · Executive Officer
  • John McClellanDirector
  • Mohamed OusseimiDirector
  • Daniel PenberthyDirector
  • Robert PorellDirector
  • Donald SackettDirector · Executive Officer

Patents

USPTO · 26 granted of 40

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.